Synchem Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 11-12-2024
- Paid Up Capital ₹ 2.13 M
as on 11-12-2024
- Company Age 24 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.14 Cr
as on 11-12-2024
- Revenue 92.56%
(FY 2022)
- Profit 868.10%
(FY 2022)
- Ebitda 7021.28%
(FY 2022)
- Net Worth 66.66%
(FY 2022)
- Total Assets 53.02%
(FY 2022)
About Synchem Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.13 M.
The company currently has active open charges totaling ₹2.14 Cr.
Dharmendra Jain, Manish Jain, and Dinesh Jain serve as directors at the Company.
- CIN/LLPIN
U24239MP2000PTC051978
- Company No.
126020
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Synchem Pharmaceuticals Private Limited offer?
Synchem Pharmaceuticals Private Limited offers a wide range of products and services, including Pharmaceutical Tablets, Pharmaceutical Syrup, Ayurvedic Herbal Syrups & Tonics, Pharmaceutical Medicine, Pharmaceutical Drug, Dry Syrups, Antihistamines, Anti Cold Tablet, Antibiotic Tablets & Capsules, Cefixime Tablet.
Who are the key members and board of directors at Synchem Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmendra Jain  | Managing Director | 19-Apr-2000 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manish Jain | Whole-Time Director | 01-Jun-2007 | Current |
| Dinesh Jain | Whole-Time Director | 19-Apr-2000 | Current |
Financial Performance of Synchem Pharmaceuticals.
Synchem Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 92.56% increase. The company also saw a substantial improvement in profitability, with a 868.1% increase in profit. The company's net worth Soared by an impressive increase of 66.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synchem Pharmaceuticals?
In 2023, Synchem Pharmaceuticals had a promoter holding of 99.44% and a public holding of 0.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 14 Jun 2021 | ₹9.00 M | Open |
State Bank Of India Creation Date: 30 Mar 2016 | ₹1.00 Cr | Open |
State Bank Of India Creation Date: 22 Apr 2002 | ₹2.40 M | Open |
How Many Employees Work at Synchem Pharmaceuticals?
Synchem Pharmaceuticals has a workforce of 159 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synchem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synchem Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
